BEXIMCO PHARMA.GDR REGS 1 Cash Flow Reinvestment Rate
BEXIMCO PHARMA.GDR REGS 1 cash flow reinvestment rate. BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Cash Flow Reinvestment Rate of 0.29x as of June 2024, reinvesting €2.43 Billion (capex €2.23 Billion plus investments €-200.00 Million) from operating cash flow of €8.36 Billion. Explore BEXIMCO PHARMA.GDR REGS 1 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of BEXIMCO PHARMA.GDR REGS 1 (2022–2024)
Cash flow reinvestment rate of BEXIMCO PHARMA.GDR REGS 1 from 2022 to 2024. Historical reinvestment intensity for BEXIMCO PHARMA.GDR REGS 1 across 3 annual periods. Explore BEXIMCO PHARMA.GDR REGS 1 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
BEXIMCO PHARMA.GDR REGS 1 Cash Flow Reinvestment Rate by Year (2022–2024)
BEXIMCO PHARMA.GDR REGS 1 cash flow reinvestment rate by year from 2022 to 2024. Year-by-year capital reinvestment analysis for BEXIMCO PHARMA.GDR REGS 1. For the full cash flow conversion analysis, see cash efficiency ratio of BEXIMCO PHARMA.GDR REGS 1.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.29x | €2.43 Billion | €8.36 Billion | €2.23 Billion | ▼ -34.6% |
| 2023 | 0.45x | €2.71 Billion | €6.08 Billion | €2.71 Billion | ▼ -21.0% |
| 2022 | 0.56x | €2.94 Billion | €5.21 Billion | €2.94 Billion | — |